Simon Farrell bought TRVI
February 15, 2024 · Form 4 insider transaction
Simon Farrell bought 175,000 shares of Trevi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
175,000
Price
$0.00
Total value
N/A
InsiderSimon Farrell
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 15, 2024
Filing dateFebruary 16, 2024
Shares owned after175,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on February 15, 2024. The 175,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028.